(AMD) Human Papillomavirus (HPV) Type 16 & 18 qPCR detection kit CE-IVD

CE-IVD marked qPCR kits for molecular diagnostics in oncology, infection detection, antimicrobial resistance, and genetic testing. Kits include all reagents with internal controls and are validated on multiple real-time PCR platforms. Assays designed to CDC and WHO standards offer high sensitivity and specificity with simplified setup and data analysis.

A molecular PCR test kit for the detection of human papillomavirus types 16 and 18. Used for cervical cancer risk assessment and screening.

A diagnostic test kit for the detection of human papillomavirus types 16 and 18 using PCR with fluorescence methodology. This kit is used to identify HPV infection status in clinical specimens.

In vitro qualitative detection kit for 18 types of high-risk HPV using fluorescence PCR technology. Suitable for urine, cervical swab, and vaginal swab samples with HPV 16/18 typing capability. CE and TFDA approved for clinical diagnostic use.

This diagnostic kit uses real-time multiple fluorescent PCR technology combined with an Automated Fully Enclosed qPCR Instrument. It is used for in vitro qualitative detection of high-risk HPV16, HPV18, and 16 other high-risk types (HPV26, HPV31, HPV33, HPV35, HPV39, HPV45, HPV51, HPV52, HPV53, HPV56, HPV58, HPV68, HPV59, HPV66, HPV73, and HPV82) in cervical exfoliated cells or reproductive tract secretions. Test results assist in HPV auxiliary diagnosis.

Multiplex real-time PCR kit for simultaneous detection and typing of human papillomavirus (HPV) 16 and 18 strains. Used in clinical diagnostics for cervical cancer screening and HPV genotyping. Enables rapid, multiplexed analysis from patient samples with high sensitivity and specificity.

PCR-based human papillomavirus detection assay capable of identifying 23 HPV genotypes including 18 high-risk and 5 low-risk variants for cervical cancer screening and auxiliary diagnosis.

Qualitatively detects high-risk human papillomavirus (HPV) DNA in cervical exfoliate cells or urine samples, including types 16, 18, 26, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 68, 73, and 82, with specific genotyping identification for types 16 and 18. It uses fluorescent PCR technology and has obtained CE certification.

PCR-based diagnostic kit for detection and differentiation of Human Papillomavirus types 16 and 18 in clinical samples. Designed for molecular screening and identification of high-risk HPV strains associated with cervical and other cancers. Ready-to-use format with optimized mastermix for rapid, reliable results in clinical and research laboratories.

Multiplex real-time PCR assay for detection and typing of human papillomavirus with specific genotyping for high-risk types 16 and 18. The kit enables rapid identification of clinically significant HPV variants.

Real-time PCR kit for simultaneous detection of HPV-16, HPV-18, and HPV-6/11 in clinical samples. CE IVDR-marked and ISO 13485-certified multiplex diagnostic reagent for cervical cancer screening and HPV risk stratification. Includes optimized primers, probes, and RNase P internal control for reliable qualitative results.

A nucleic acid detection kit designed to identify 14 types of high-risk human papillomavirus (HPV) with specific genotyping for HPV types 16 and 18. This test kit enables comprehensive HPV screening and risk stratification for cervical cancer prevention. The kit provides detailed genotyping information for clinical management and patient counseling.